Fractional Flow Reserve (FFR) Versus Instant Wave-Free Ratio (iFR)
NCT ID: NCT01559493
Last Updated: 2012-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2012-01-31
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* To compare FFR to iFR in arbitrary consecutive patients referred for percutaneous coronary intervention (PCI).
* To investigate the influence of hyperemia on iFR.
* To test reproducibility of iFR and FFR.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of iFR vs FFR in Stable Angina or Acute Coronary Syndrome
NCT02166736
INTegrated Assessment of intERmediate Coronary Stenoses by Fractional Flow rEserve (FFR) and Near-infraREd Spectroscopy (NIRS)
NCT02985112
Pd/Pa vs iFR™ in an Unselected Population Referred for Invasive Angiography
NCT02377310
Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation
NCT02053038
FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocardial Infarction
NCT02943954
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FFR; iFR
Interventional Cardiology, Pressure wire, fractional flow reserve, coronary flow measurement
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* extremely tortuous, calcified lesions
* coronary artery occlusion
* acute MI within 5 days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Golden Jubilee National Hospital
OTHER_GOV
Catharina Ziekenhuis Eindhoven
OTHER
Onze Lieve Vrouw Hospital
OTHER
Stockholm South General Hospital
OTHER
Brno University Hospital
OTHER
Stanford University
OTHER
NHS National Waiting Times Centre Board
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Keith G. Oldroyd
Consultant Cardiologist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Prof Keith G. Oldroyd
Role: PRINCIPAL_INVESTIGATOR
Golden Jubilee National Hospital
Prof Colin Berry, MD
Role: PRINCIPAL_INVESTIGATOR
Golden Jubilee National Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford University
Stanford, California, United States
Cardiovascular Center Aalst
Aalst, , Belgium
University Hospital Brno
Brno, , Czechia
Catharina Ziekenhuis
Eindhoven, , Netherlands
Stockholm South Hospital
Stockholm, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Berry C, van 't Veer M, Witt N, Kala P, Bocek O, Pyxaras SA, McClure JD, Fearon WF, Barbato E, Tonino PA, De Bruyne B, Pijls NH, Oldroyd KG. VERIFY (VERification of Instantaneous Wave-Free Ratio and Fractional Flow Reserve for the Assessment of Coronary Artery Stenosis Severity in EverydaY Practice): a multicenter study in consecutive patients. J Am Coll Cardiol. 2013 Apr 2;61(13):1421-7. doi: 10.1016/j.jacc.2012.09.065. Epub 2013 Feb 6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Version F 2nd Jan 2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.